✦ The Short Version
It has a real trial, with limits. NeuropAWAY’s capsules are the only nerve supplement I’ve reviewed with a published, randomized, placebo-controlled trial of the finished product. It was small (59 people), six weeks long and company-funded, and it used 6 capsules a day, three times the label serving.
Most doses aren’t on the label. Apart from B12, the five active ingredients sit in a proprietary blend with no individual amounts. The gel, its most-searched product, is a different product, and the trial didn’t test it.
Check the PM formula. It contains 15 mg of melatonin per capsule, according to the brand’s own label image, and the directions allow up to four.
A bottle is not a plan. At the studied dose, NeuropAWAY runs $1.90 to $2.50 a day, about the same as NeuroAxis, the formula I developed. NeuroAxis puts every dose on the label and includes a 160-page nutrition and lifestyle Protocol. It has no randomized trial of its own, and I formulated it, so weigh that conflict and check my numbers. Every one is sourced and dated.
✦ The 30-Second Comparison
NeuropAWAY vs NeuroAxis + the NeuroAxis Protocol
| NeuropAWAY | NeuroAxis | |
|---|---|---|
| Published trial of the finished product | Yes: one 6-week trial, 59 people | Yes: two small, non-randomized studies under its earlier name, NeuroGen, after carpal tunnel surgery (not neuropathy) |
| Who formulated it | Patent inventor: VasoCorp founder William Cross | A fellowship-trained peripheral nerve surgeon (me) |
| Core three at trial doses | ALA amount hidden; B12 below; no benfotiamine | All three |
| Every dose on the label | B12 only (rest in a 1,200 mg blend) | Yes |
| Nerve pathways reached | Amounts hidden; no B1 pathway | All four + B-vitamin layer |
| Nutrition & lifestyle plan | None | 160-page Protocol, free |
| Talk to the person who formulated it | No | Free 10-minute call |
I formulated NeuroAxis, so weigh that. Every number in this table is sourced in the review below.
| Get NeuroAxis + the Free 160-Page Protocol → |
| Not sure it fits you? Free 10-minute call with me → |
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Not ready to buy anything? Start with the free Nerve Health Blueprint
The nutrition, lifestyle and testing framework I used with patients over 20+ years as a peripheral nerve surgeon, in one free guide.
Get the Free Blueprint →Dr. Michael Fitzmaurice, MD
Fellowship-Trained Peripheral Nerve Surgeon & Metabolic Health Educator · About Dr. Fitzmaurice
“When I read a surgical study, the first question was never whether it worked. It was whether my patient looked like the people in the study, at the dose and for the length of time they were followed. A supplement trial deserves the same question.”
Most nerve supplement reviews, including most of mine, end in the same place: the ingredients have some evidence, but nobody has tested the finished bottle. NeuropAWAY breaks that pattern. Its maker, VasoCorp, paid for and published a randomized, double-blind, placebo-controlled trial of its capsule formula. Most brands in this category never do that, and I want to say so plainly before I say anything else.
That makes this a different kind of review. The usual question, “does the label match the research?”, turns into a more interesting one: what does this particular trial tell you about the product you’d actually buy, at the dose you’d actually take? The answer depends on details most reviews skip. Who was enrolled. How many capsules they took. What happened in the placebo group. And which NeuropAWAY product the trial actually tested, because the most-searched one, the gel, wasn’t it.
Over more than 20 years as a peripheral nerve surgeon, I performed more than 3,000 nerve procedures and read the surgical literature the way surgeons have to: looking for the gap between what a study showed and what it would mean for the person in front of me. I’ve applied the same reading here, to the trial paper, the Supplement Facts panels on the brand’s own product pages, the retail listings and the price.
A disclosure before we start. I formulated NeuroAxis, a nerve support supplement sold on this site, and I authored the two published studies of this same formula under its earlier name, NeuroGen. That’s a conflict of interest, and you should weigh it. It’s also why every statement about NeuropAWAY below comes from its label, the brand’s pages, a retailer listing, a government record or a published study, with the date I checked it, and why NeuroAxis appears later on the same yardstick, including the fact that NeuropAWAY has a stronger trial than NeuroAxis does.
What You Will Learn
➤ What NeuropAWAY is, who makes it, and the four products in the line
➤ What’s on the capsule label, and what isn’t
➤ What the NeuropAWAY clinical trial found, and what to weigh before applying it to yourself
➤ What’s in NeuropAWAY gel, and whether it was tested
➤ What’s in NeuropAWAY PM, including the melatonin amount
➤ Why the dose question (2 capsules vs 6) changes the price completely
➤ NeuropAWAY side effects, ratings, complaints and the refund policy
➤ How NeuropAWAY compares with NeuroAxis on disclosed doses, pathways, price and the program that comes with it
What Is NeuropAWAY?
NeuropAWAY is a line of nerve support products from VasoCorp, Inc., a family-owned company in Hiram, Georgia, founded by its president, William (Bill) Cross. The brand’s own store, at vasocorp.com (neuropaway.com redirects there), describes the products as made in the USA and states that more than 100,000 customers use them. I report those as the brand’s statements.
Where to buy NeuropAWAY. On November 4, 2026, NeuropAWAY products were sold on vasocorp.com, Amazon and Walmart, in CVS, and in Kroger-family stores and H-E-B. The brand’s site also shows a Walgreens logo.
The product line. On November 4, 2026, the brand’s own store listed three NeuropAWAY products. A fourth, Kidney Support, is sold through retailers.
| Product | Format | What it is |
|---|---|---|
| Nerve Support Formula (the capsules or “pills”) | 60 capsules (a 120-capsule size is also listed); serving 2 capsules | The product the published trial tested. Methylcobalamin plus a proprietary blend. |
| NeuropAWAY PM | 60 capsules; serving 1 capsule | A nighttime formula: methylcobalamin, a proprietary blend and 15 mg of melatonin per capsule. |
| Maximum Strength Gel | 2 oz and 6 oz | A topical gel the brand labels a cosmetic. Allantoin, vitamin E, CoQ10, vitamin D3, acetyl-L-carnitine. |
| Kidney Support Formula | Capsules | Not a nerve product. Covered briefly below. |
A menthol-free spray has also been sold under the NeuropAWAY name. It wasn’t listed on the brand’s store when I checked.
NeuropAWAY vs NeuroAxis at a Glance
Before the details, here’s the comparison most readers come for. I formulated NeuroAxis, so read this table knowing that, and check every number against the sources at the end.
| NeuropAWAY capsules | NeuroAxis | |
|---|---|---|
| Published trial of the finished product | Yes: one randomized, placebo-controlled, six-week trial (59 people) | Yes: two small, non-randomized studies under its earlier name, NeuroGen, after carpal tunnel surgery (not neuropathy) |
| Doses on the label | B12 only; five ingredients in a 1,200 mg proprietary blend | Every ingredient, every amount |
| Alpha-lipoic acid | R-ALA, amount not disclosed (no more than 240 mg per serving by label order; see below) | 600 mg R-ALA, the studied dose |
| Methylcobalamin (B12) | 240 mcg (720 mcg at trial dose) | 2,000 mcg |
| Benfotiamine (B1) | None | 300 mg |
| Antioxidant, mitochondrial and tissue-environment support | Taurine, acetyl-L-carnitine and R-ALA, amounts undisclosed | NAC 900 mg, acetyl-L-carnitine 600 mg, CoQ10 150 mg, curcumin 500 mg, bromelain, serrapeptase |
| Circulation support | L-citrulline and taurine (amounts undisclosed) | Not targeted directly |
| Daily pills at the studied or standard dose | 6 capsules | 6 tablets |
| Cost per day at that dose | $1.90 to $2.50 | About $2.00 (subscription) |
| Nutrition and lifestyle program | None found | 160-page NeuroAxis Protocol included |
| Direct access to the formulator | No | Free 10-minute call with me |
NeuropAWAY figures from its Supplement Facts panel, the 2023 trial paper and retail prices, November 4, 2026. NeuroAxis figures from its label and drfitznutrition.com pricing.
Each row has a section below.
NeuropAWAY Ingredients: What the Label Shows, and What It Doesn’t
Here is the NeuropAWAY Nerve Support Formula Supplement Facts panel, from the label image on the brand’s capsule product page.
| Per 2-capsule serving | Amount |
|---|---|
| Vitamin B12 (as methylcobalamin) | 240 mcg (10,000% DV) |
| Proprietary blend: taurine, acetyl-L-carnitine, L-citrulline, beta-alanine, R-alpha-lipoic acid | 1,200 mg total; individual amounts not disclosed |
| Other ingredients | Gelatin capsule, silica, magnesium stearate |
Source: Supplement Facts and dosing image on vasocorp.com/products/neuropaway-capsules, reviewed November 4, 2026.
What a proprietary blend means. The label tells you the five ingredients and their combined weight, 1,200 mg, listed in descending order by weight. It doesn’t tell you how much of each one you’re getting. That’s legal for supplements, and it’s common. It also means you can’t compare NeuropAWAY’s alpha-lipoic acid or acetyl-L-carnitine with the doses used in research, because those numbers aren’t on the bottle.
What each ingredient is there for. Taurine is an amino acid that nerve cells use to regulate volume and calcium. High blood sugar depletes it in nerve tissue, and in diabetic animals taurine supplementation improved nerve blood flow and conduction. Acetyl-L-carnitine (ALCAR) helps move fuel into mitochondria and has the most human neuropathy data of the group after ALA. L-citrulline is converted to arginine and then nitric oxide, which relaxes blood vessels. R-alpha-lipoic acid (R-ALA) is the natural form of the antioxidant ALA, the best-studied nutrient for diabetic neuropathy symptoms. Beta-alanine is a sports-nutrition amino acid. More on that one in a moment.
On my usual yardstick. In my neuropathy supplement reviews, I check every formula against the three ingredients with the strongest human evidence, at the doses that were studied.
| Core ingredient | Studied dose | NeuropAWAY, 2 capsules | NeuropAWAY, 6 capsules (trial dose) |
|---|---|---|---|
| Alpha-lipoic acid | 600 mg (SYDNEY 2) | Undisclosed (R-ALA, in the blend) | Undisclosed |
| Methylcobalamin (B12) | About 1,500 mcg | 240 mcg (below) | 720 mcg (below) |
| Benfotiamine (B1) | 300 to 600 mg (BENDIP) | Absent | Absent |
| Acetyl-L-carnitine | 1,500 to 3,000 mg (Sima 2005) | Undisclosed | Undisclosed |
| All doses disclosed? | No | No |
On that yardstick NeuropAWAY can’t be scored, because the amounts that matter aren’t on the label. It uses the R form of ALA, which is a point in its favor, though no neuropathy trial has shown R-ALA beats standard ALA for symptoms. My alpha-lipoic acid for neuropathy guide covers that question.
What NeuropAWAY has that the other products in my reviews don’t is a trial of the finished formula. So the label isn’t the end of this review. But it’s worth understanding exactly what the blend hides first.
Proprietary Blend vs Listed Doses: Why It Matters
A proprietary blend lets a company list a group of ingredients under one combined weight without saying how much of each is inside. It’s legal, it’s common, and companies often say it protects their formula. For you, it has three practical consequences.
1. You can’t check the dose against the research. Alpha-lipoic acid was studied at 600 mg a day in the SYDNEY 2 trial. Acetyl-L-carnitine was studied at 1,500 to 3,000 mg. With a blend, you can’t tell whether NeuropAWAY gets anywhere near either one.
2. You can’t add up your totals. If you also take a separate ALA, B vitamin or amino acid supplement, you don’t know your combined intake. That matters most for ALA, which can lower blood sugar.
3. You can’t adjust one ingredient. If ALA upsets your stomach, or your doctor wants more B12, a disclosed label lets you see what you’d be changing. A blend doesn’t.
What the Label Order Does Tell You
There’s one thing a blend can’t hide. Under FDA labeling rules (21 CFR 101.36), ingredients in a proprietary blend must be listed in descending order by weight. NeuropAWAY’s capsule label lists them in this order: taurine, acetyl-L-carnitine, L-citrulline, beta-alanine, then R-alpha-lipoic acid last.
That allows simple arithmetic. If R-ALA is the smallest of five ingredients in a 1,200 mg blend, it can be no more than one-fifth of the blend.
| At 2 capsules (serving) | At 6 capsules (trial dose) | Studied dose | |
|---|---|---|---|
| R-alpha-lipoic acid, maximum possible | 240 mg | 720 mg | 600 mg (SYDNEY 2) |
| Acetyl-L-carnitine, maximum possible | 600 mg | 1,800 mg | 1,500 to 3,000 mg (Sima 2005) |
Maximums assume the label follows the descending-order rule. Acetyl-L-carnitine is listed second, so it can be no more than half the blend. The real amounts are lower than these ceilings unless the ingredients listed ahead of them are present in exactly equal amounts.
So at the standard 2-capsule serving, NeuropAWAY’s R-ALA is at most 240 mg, well under half the studied dose, and probably less. Even at the 6-capsule trial dose, it can’t reach 720 mg. I’m not saying the formula doesn’t work: the trial tested the whole blend, and it can’t tell you which ingredient did what. I’m saying the label doesn’t let you compare its ingredients with the research behind them, and the label order puts a ceiling on how close the ALA can be.
Compare that with a disclosed label. NeuroAxis lists 600 mg of R-alpha-lipoic acid, 2,000 mcg of methylcobalamin, 300 mg of benfotiamine, 600 mg of acetyl-L-carnitine and every other amount on the label. You can check each one against the trials yourself, and I’d encourage you to. That’s the standard I hold my own formula to, and it’s why I put every amount on the bottle.
✦ KEY TAKEAWAY: NeuropAWAY’s blend lists R-alpha-lipoic acid last of five ingredients. By FDA’s descending-order rule, that means no more than 240 mg per serving, against a studied dose of 600 mg. A disclosed label lets you check every dose. A blend asks you to trust it.

A proprietary blend lists ingredients without amounts. A disclosed label lets you check every dose against the research.
The Beta-Alanine Question
Beta-alanine is best known in sports nutrition, where people take it to buffer acid in working muscle. Its best-known side effect is a harmless, temporary tingling or prickling of the skin, called paresthesia, that usually starts soon after a dose and fades on its own.
The trial paper discusses this directly. The authors note that beta-alanine produces heat and tingling sensations and propose it as part of how the formula affects painful sensation. I’m not going to speculate about what it did in the trial. But if you have tingling feet, you deserve to know that one of the five ingredients is known to cause tingling, so you can tell the difference if you notice it after a dose. NeuropAWAY PM contains beta-alanine too.
The NeuropAWAY Clinical Trial, Explained
The study is Cross W and Srivastava S, “A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy of a Nerve Support Formula on Neuropathic Pain in Individuals Suffering from Type II Diabetes Mellitus,” Journal of Pain Research, 2023. The full text is free on PubMed Central, and the trial was registered on ClinicalTrials.gov (NCT04504305).
What the Trial Did
• Who ran it: Vedic Lifesciences, a contract research organization in India, between August 2020 and February 2021. An independent ethics committee in Ahmedabad approved the protocol.
• Who was enrolled: adults 40 to 65 with type 2 diabetes for more than a year, all taking metformin, with an A1C between 7.1% and 9.5% and painful diabetic neuropathy rated at least 6 out of 10.
• Who was excluded: people on insulin, people taking PDE5 inhibitors (sildenafil and similar drugs), people with uncontrolled blood pressure, kidney insufficiency, recent foot ulcers, chemotherapy in the past five years, or nerve damage from other causes, and people already taking taurine, citrulline or other amino acid supplements.
• How many: 64 randomized, 59 analyzed (27 on the formula, 32 on placebo).
• What they took: 2 capsules three times a day, half an hour before meals, which is 6 capsules a day, for 42 days. The placebo was microcrystalline cellulose in matching capsules.
What It Found
These are the paper’s numbers.
• Pain (0 to 10 scale): in the formula group, average pain fell from about 7.8 to about 3.0, a drop of 4.78 points (61%). In the placebo group it rose slightly, by 2.5%. The difference between groups was statistically significant from day 7 onward.
• Responders: by day 42, 93% of the formula group had at least a 30% improvement on the Brief Pain Inventory and 85% had at least a 50% improvement. In the placebo group, no one reached either threshold at any point.
• Symptoms and sleep: the formula group improved on all six items of a standard neuropathy symptom score (numbness, tingling, burning, aching, shooting pain and allodynia) and on an insomnia scale. On both, the placebo group got slightly worse.
• B12: blood B12 rose in the formula group and fell in the placebo group.
• Nerve function: no significant difference. Nerve conduction velocity and leg blood flow didn’t differ between groups at 42 days. The authors say these measures would need a trial of six months or longer.
• Safety: no adverse events were reported in either group over six weeks.

Pain scores in the 2023 NeuropAWAY trial. Small (59 people), six weeks, 6 capsules a day, company-funded, and the placebo group barely changed.
What to Weigh Before You Apply It to Yourself
Here’s how I’d read this trial if a patient brought it to me.
Who paid for it, and who wrote it. VasoCorp funded the study. The first author is VasoCorp’s founder, who is the named inventor on the formula’s patent and discloses it in the paper. Industry-funded trials are common, including most of the drug trials behind prescription nerve-pain medications, and funding doesn’t make a result wrong. It does make independent replication matter more.
It hasn’t been replicated. A PubMed search on November 4, 2026 found no other published trial of this formula. One trial of 59 people is a starting point, not a settled answer.
It was short. Six weeks tells you about symptoms in the short term. It doesn’t tell you about nerve structure, and the paper found no change in nerve conduction. That’s expected: injured peripheral nerve fibers regrow at roughly 1 mm a day, about an inch a month, so long-term nerve recovery in the feet is measured in months to years, not weeks. Short-term symptom relief and nerve repair are different outcomes, and the trial measured the first. My guide to how long nerve supplements take to work covers what the trials actually tracked.
The placebo group barely moved. This is the detail I’d most want a reader to understand. In painful diabetic neuropathy trials, the placebo group usually improves noticeably. A 2024 meta-analysis in the journal Pain pooled 21 placebo-controlled trials with 2,425 placebo-treated patients and found an average placebo drop of about 1.5 points on a 0 to 10 pain scale, with about 25% of placebo patients reaching a 50% pain reduction. In the NeuropAWAY trial, the placebo group’s pain rose slightly, and none of the 32 placebo participants reached even a 30% improvement. I’m not suggesting anything about why. I’m pointing out that this placebo result is very different from what most trials in this condition report, which is one more reason the finding needs to be repeated by an independent group before anyone treats the size of the effect as reliable.
Everyone started out B12-deficient. Both groups had low B12 at the start, and all participants were on metformin, a diabetes drug known to lower B12 over time. The formula contains methylcobalamin, and B12 levels rose in the formula group. Correcting a deficiency can relieve nerve symptoms on its own. That means the result may not predict what happens in someone whose B12 is already normal. If you take metformin, getting your B12 checked is worth doing whatever supplement you choose. My article on why B12 isn’t always helping neuropathy explains the testing.
It tested one product, at one dose. The trial tested the daytime capsule at 6 capsules a day. It didn’t test 2 capsules a day, the PM formula, the gel or the spray.
Who it applies to. Adults 40 to 65 with type 2 diabetes on metformin, not on insulin, with moderate painful neuropathy. If your neuropathy comes from chemotherapy, alcohol, an autoimmune process, nerve compression or no known cause, or if you use insulin, the trial didn’t include you.
The paper’s own conclusion goes further than I would, and compares its result with prescription drugs studied in other trials. Cross-trial comparisons like that can’t tell you which works better, because the people, the measures and the placebo responses differ between studies. I’ve stuck to what was measured.
✦ KEY TAKEAWAY: NeuropAWAY has more published evidence for its own finished formula than any other brand I’ve reviewed. It’s also one small, six-week, company-funded trial in B12-deficient people with type 2 diabetes, at 6 capsules a day, with an unusually flat placebo group, and the doses inside the blend still aren’t on the label.
NeuropAWAY Gel and Cream: What’s in It, and Was It Tested?
NeuropAWAY gel is the most-searched product in the line, and it’s the one most often confused with the capsules.
What the brand says it is. On November 4, 2026, the brand’s product page described NeuropAWAY Maximum Strength Gel as a fast-absorbing topical gel “for the occasional burning and tingling of dry, flaky skin on feet, legs and hands.” It lists allantoin (a skin-soothing compound), vitamin E, CoQ10, vitamin D3 and acetyl-L-carnitine. The page says it is made under cosmetic good manufacturing practices, advises a patch test before first use and is for external use only. Its disclaimer states: “This product is a cosmetic.”
Why that matters. Topical products that relieve pain with an active drug ingredient, such as lidocaine, menthol or capsaicin, carry a “Drug Facts” panel and are regulated as over-the-counter drugs. NeuropAWAY gel is labeled as a cosmetic, with no drug ingredient. It’s menthol-free and capsaicin-free. It’s meant to condition and soothe the skin.
Can the nutrients reach your nerves through the skin? CoQ10 and acetyl-L-carnitine are studied as oral supplements for nerves. A PubMed search on November 4, 2026 found no study testing whether either one, applied to the skin, reaches peripheral nerves or changes nerve symptoms in people. That doesn’t mean it can’t. It means no one has shown it.
The key point: the trial tested the capsules, not the gel. “Clinically studied” on the capsule doesn’t carry over to the gel. Many shoppers will assume it does.
How the brand says to use it. A thin layer 3 to 4 times a day for the first 7 to 10 days, then as needed. A 2 oz tube was $19.99 on the brand’s site (on sale from $25.00) and $18.97 on Amazon, where it showed 4.0 out of 5 stars from 2,565 ratings on November 4, 2026.
If you want a topical option for nerve pain, products with tested drug ingredients exist, and a pharmacist can help you choose one that fits your medications. My evidence review of nerve supplements covers what’s been tested.

The trial tested the capsules. The gel is a different product, labeled as a cosmetic, and wasn’t studied.
NeuropAWAY PM: What’s in It
Here is the NeuropAWAY PM Supplement Facts panel, from the label image on the brand’s PM product page.
| Per 1-capsule serving | Amount |
|---|---|
| Vitamin B12 (as methylcobalamin) | 120 mcg |
| Proprietary blend: taurine, acetyl-L-carnitine, L-theanine, beta-alanine, R-alpha-lipoic acid | 600 mg total; individual amounts not disclosed |
| Melatonin | 15 mg |
Source: Supplement Facts image on vasocorp.com/products/neuropaway-pm, reviewed November 4, 2026. Directions on the same image: 1 to 4 capsules, 30 minutes before bedtime.
The melatonin amount. Each capsule contains 15 mg of melatonin, and the directions allow 1 to 4 capsules. That’s 15 to 60 mg a night. The NIH’s National Center for Complementary and Integrative Health lists sleepiness, headache, dizziness and nausea among the side effects reported in short-term melatonin studies, and notes that long-term effects are unclear. If you take PM, start at one capsule, notice how you feel the next morning, and don’t drive if you’re groggy. If you take blood pressure medication, blood thinners, sedatives or diabetes medication, check the melatonin with your pharmacist.
The trial didn’t test PM. It’s a different formula, with half the B12 and blend per serving, L-theanine in place of L-citrulline, and melatonin.
For comparison, Nervive Nerve Relief PM lists 2 mg of melatonin per tablet. My Nervive review covers that formula.
How Many NeuropAWAY Capsules Should You Take? 2 vs 6
This is where the trial and the shelf diverge.
What the label says. The dosing image on the brand’s capsule page gives a serving size of 2 capsules and a two-stage schedule: a “loading dose” in week 1 of 2 capsules three times a day (6 capsules a day), then 1 to 3 servings a day (2 to 6 capsules) or as needed from week 2 onward. Retail listings give the shorter version: 1 to 3 servings a day.
What the trial used. 6 capsules a day, every day, for six weeks.
What that means for you. If you take 2 capsules a day, you’re taking a third of the dose that was studied. The trial doesn’t tell you what happens at that dose. If you want the dose that was studied, it’s 6 capsules a day, and a 60-capsule bottle lasts 10 days.
| 2 capsules a day | 6 capsules a day (trial dose) | |
|---|---|---|
| Methylcobalamin | 240 mcg | 720 mcg |
| Proprietary blend | 1,200 mg | 3,600 mg |
| How long a 60-capsule bottle lasts | 30 days | 10 days |
| Tested in the trial? | No | Yes (six weeks) |
| Cost per day (Amazon/Walmart, $18.97) | $0.63 | $1.90 |
Even following the label’s own schedule, the loading week uses 42 capsules, so the first bottle lasts about 16 days if you then drop to 2 capsules a day.
Taking capsules half an hour before meals, as the trial did, is a reasonable way to match the study. If alpha-lipoic acid upsets your stomach on an empty stomach, which is common, talk with your pharmacist before changing the timing.

At the dose the trial tested, a 60-capsule bottle lasts 10 days.
Same price at the studied dose. Every amount on the label.
At 6 capsules a day, NeuropAWAY costs $1.90 to $2.50 a day. NeuroAxis costs about $2.00 a day on subscription, and every dose is on the label: 600 mg R-alpha-lipoic acid, 2,000 mcg methylcobalamin and 300 mg benfotiamine, plus NAC, 600 mg acetyl-L-carnitine, CoQ10, curcumin, bromelain and serrapeptase.*
The bigger difference is what comes with it. Every order includes the 160-page NeuroAxis Protocol: a nutrition plan, an exercise, sleep and lifestyle plan, and a way to track whether it’s working. And if questions come up, you can book a free 10-minute call with me.
See NeuroAxis + the 160-Page Protocol →*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
NeuropAWAY Side Effects
Most people searching “NeuropAWAY side effects” are really asking about the ingredients. For most adults the risk is low. The trial reported no adverse events over six weeks in 27 people taking the formula, which is reassuring, but 27 people for six weeks is too few to catch uncommon side effects. Here’s what applies, ingredient by ingredient.
R-alpha-lipoic acid: stomach upset and blood sugar. Nausea and heartburn are the most common complaints with alpha-lipoic acid. ALA can also lower blood glucose, which matters because NeuropAWAY is marketed to people with diabetes. If you take insulin or a sulfonylurea, talk with your doctor and monitor more closely when you start. A rare autoimmune form of low blood sugar has been reported with ALA.
Beta-alanine: harmless tingling. A temporary prickling or flushing of the skin, usually within half an hour of a dose. It isn’t nerve damage, but it can be confusing if you’re tracking tingling symptoms.
L-citrulline: blood pressure. L-citrulline raises arginine and nitric oxide, which relaxes blood vessels and may lower blood pressure. The trial excluded people taking PDE5 inhibitors such as sildenafil or tadalafil and people with uncontrolled blood pressure. If you take either kind of medication, check with your pharmacist first.
Acetyl-L-carnitine and chemotherapy. In the SWOG S0715 trial, acetyl-L-carnitine taken during taxane chemotherapy was associated with worse neuropathy at 24 weeks than placebo. That caution applies to any product containing it. The trial excluded anyone who’d had chemotherapy in the previous five years. If you’re receiving chemotherapy, ask your oncologist before taking any nerve supplement. My evidence review covers that trial.
Taurine and methylcobalamin are generally well tolerated.
NeuropAWAY PM: melatonin. At 15 mg per capsule, next-day sleepiness is the side effect to watch for, along with headache, dizziness and nausea. See the PM section above.
NeuropAWAY gel. Skin irritation is possible with any topical. The brand advises a patch test on a small area first.
Kidney disease. The trial excluded people with kidney insufficiency. If you have reduced kidney function, ask your doctor before taking any amino acid supplement.
The larger risk isn’t on any label. It’s the opportunity cost: months on a supplement while an untreated B12 deficiency, a rising A1C or a compressed nerve keeps doing damage.
NeuropAWAY Reviews and Complaints
On November 4, 2026, NeuropAWAY capsules showed 4.4 out of 5 from 698 ratings on Walmart and 4.3 out of 5 from 30 reviews on CVS. The gel showed 4.0 out of 5 from 2,565 ratings on Amazon. NeuropAWAY PM showed 3.8 out of 5 from 17 reviews on CVS.
A few things are worth knowing when you read them.
Ratings can’t do what the trial did. None of them can separate the product from placebo, from natural ups and downs in symptoms or from other changes the reviewer made. That’s exactly why the controlled trial matters more than any star count, and why its limits matter too.
Check which product and dose the reviewer took. A five-star review of the gel says nothing about the capsules, and someone taking 2 capsules a day isn’t taking what the trial tested.
How to spot the useful reviews. Look for a verified-purchase tag, a specific description of symptoms (where, what kind, how long), how many capsules the person took and for how long, and both good and bad experiences. Honest ratings for any supplement usually spread across the scale in a rough bell curve, because people with different causes of neuropathy respond differently. Promotional testimonials and brand-page quotes tend to describe only the best results.
Supplements aren’t approved before they’re sold. The FDA doesn’t review dietary supplements for safety or effectiveness before they reach the shelf. That applies to every nerve supplement, NeuroAxis included. Supplements may make structure/function claims such as “supports healthy nerve function,” with a required FDA disclaimer, and companies are responsible for making sure their claims are supported.
Themes worth planning for: stomach upset with the capsules, next-day grogginess with PM, and cost once you realize the studied dose is 6 capsules a day.
FDA warning letter. In a warning letter dated July 9, 2026, posted on FDA.gov, the FDA told VasoCorp that claims it reviewed on vasocorp.com in March 2026 for the Nerve Support Formula and NeuropAWAY PM made those products drugs under federal law, because the claims described them as intended to treat or mitigate disease. The claims the letter quoted included a statement that the formula is “clinically proven” to reduce symptoms, and the trial’s pain-score result. A warning letter states FDA’s position; the company can respond to it. When I checked the brand’s product pages on November 4, 2026, they used structure/function wording with the standard FDA disclaimer. I’m reporting this because it’s a public record and relevant to anyone searching for complaints, not as a judgment about the product.
NeuropAWAY Price and the Real Cost at the Studied Dose
Here’s what each channel charged for the 60-capsule Nerve Support Formula on November 4, 2026.
| Where | Price (60 capsules) | Per day at 2 capsules (30 days) | Per day at 6 capsules (10 days) | 30 days at 6 capsules |
|---|---|---|---|---|
| Amazon | $18.97 | $0.63 | $1.90 | $56.91 |
| Walmart | $18.97 | $0.63 | $1.90 | $56.91 |
| H-E-B | $19.80 | $0.66 | $1.98 | $59.40 |
| Kroger-family stores (Mariano’s) | $19.99 | $0.67 | $2.00 | $59.97 |
| vasocorp.com (sale price, free shipping) | $19.99 | $0.67 | $2.00 | $59.97 |
| vasocorp.com (regular price) | $24.99 | $0.83 | $2.50 | $74.97 |
vasocorp.com also lists a 120-capsule size, which showed no price when I checked. NeuropAWAY PM and the 2 oz gel were $18.97 on Amazon and $19.99 on vasocorp.com.
The point. At 2 capsules a day, NeuropAWAY is one of the least expensive nerve supplements I’ve reviewed. But 2 capsules a day isn’t what was studied. At the trial dose, a month costs about $57 to $75, three bottles, and that’s roughly the same per day as NeuroAxis on subscription.
The refund policy. As written on vasocorp.com on November 4, 2026: you have 45 days to request a full refund, less shipping and handling, and refunds go back to the original payment method within 10 to 14 days. The product pages describe this as a “30-Day Guarantee,” so the two pages give different windows; the refund policy page is the more specific one. Purchases from retailers follow each retailer’s own return policy.
NeuropAWAY Kidney Support
NeuropAWAY Kidney Support isn’t a nerve product, and I don’t evaluate it here. It wasn’t listed on the brand’s own store on November 4, 2026, and the ingredient panels on different retail listings didn’t match each other, so check the label on the bottle you’re considering. I found no published trial of it. If you have kidney disease or reduced kidney function, talk with your nephrologist before taking any supplement, including this one.
✦ PRACTICAL TOOL: The NeuropAWAY Bottle Check
1. Which product is it? Capsules, PM or gel. Only the capsules were tested in the trial.
2. How many capsules are you taking? The trial used 6 a day. Write down your number and what it costs per month at that dose.
3. Do you look like the trial participants? Type 2 diabetes, on metformin, not on insulin, age 40 to 65. If not, the trial’s result is a weaker guide for you.
4. Has your B12 been checked? Everyone in the trial was B12-deficient. If you take metformin, ask for a B12 level, ideally with methylmalonic acid.
5. Check your medication list. Diabetes medication, blood pressure medication, a PDE5 inhibitor, a blood thinner, sedatives (for PM) or chemotherapy means a conversation with your pharmacist first. Bring the label.
6. Write down your baseline. Rate burning, tingling, numbness and sleep from 0 to 10 before you start, then again at 2, 6 and 12 weeks. My free Nerve Symptom Tracker does this for you.
The Bigger Question: What Is Driving Your Symptoms?
No label review answers the most important question, which is why your nerves are misbehaving in the first place. Peripheral neuropathy has well over a hundred causes, including diabetes and prediabetes, B12 and other vitamin deficiencies, thyroid disease, alcohol, chemotherapy, medications and nerve compression. Many need cause-specific treatment that no supplement provides. If you’re not sure what’s behind your symptoms, start with which test detects neuropathy. Cold, numb feet aren’t always nerves either: circulation problems can look similar, which I cover in neuropathy vs poor circulation. If your blood sugar has been creeping up, how high blood sugar damages nerves explains why glucose control does more for diabetic nerves than any capsule. And if you’re wondering what your foot symptoms mean, see neuropathy in feet symptoms.
Set realistic expectations for any supplement, including mine. In the best trials, nerve supplements provide modest symptom relief in some people. They rarely cure nerve pain, and they don’t replace treating the cause. Peripheral nerve health depends far more on blood sugar, B12 status, circulation and activity than on any capsule.
Symptoms in one hand or one foot rather than both, weakness, or rapid progression are reasons to be evaluated promptly.
Already tried NeuropAWAY or another nerve supplement and not sure why it didn’t help?
That’s usually a question about the cause, not the bottle. Book a free 10-minute call with me and we’ll talk through what might be driving your symptoms.
Book a Free 10-Minute Call →Four Nerve-Support Pathways: NeuropAWAY vs NeuroAxis
Diabetic neuropathy isn’t one injury. Poor metabolic health, especially high blood sugar, damages nerves through several overlapping processes, and a formula is only as broad as the pathways it actually addresses, at doses you can verify. Here’s how the two formulas line up.
| Pathway | What goes wrong | NeuropAWAY | NeuroAxis |
|---|---|---|---|
| Oxidative stress (antioxidant support) | Excess glucose generates reactive oxygen molecules that damage nerve membranes and mitochondria | R-ALA (no more than 240 mg per serving), taurine; amounts undisclosed | R-ALA 600 mg; NAC 900 mg, a precursor to glutathione, the nerve cell’s main internal antioxidant |
| B-vitamin repair and myelin | B12 and B1 shortfalls impair myelin upkeep and glucose handling in nerve cells | Methylcobalamin 240 mcg (720 mcg at trial dose); no B1 | Methylcobalamin 2,000 mcg, benfotiamine 300 mg, B6 10 mg |
| Mitochondrial energy | Long axons need steady energy, and damaged mitochondria fall behind | Acetyl-L-carnitine, amount undisclosed | Acetyl-L-carnitine 600 mg, CoQ10 150 mg |
| Inflammation and tissue environment | Inflammation and swelling around nerves add pressure and slow recovery | Not targeted | Curcumin 500 mg with BioPerine, bromelain 600 GDU, serrapeptase 40,000 SU |
| Circulation | Small blood vessels feeding the nerves narrow and stiffen | L-citrulline, taurine; amounts undisclosed | Not targeted directly |
NeuropAWAY ceilings from the label order, as explained above. NeuroAxis amounts from its label. Check the bottle you buy to confirm the current amounts.
Two honest notes on this table. NeuropAWAY addresses circulation through L-citrulline, and NeuroAxis doesn’t target that pathway directly. And more pathways on a label doesn’t prove better results: no study has compared these two formulas, or tested NeuroAxis against its own ingredients. What the table shows is coverage you can verify. The swelling and scarring I saw around compressed nerves in the operating room is the reason I built the tissue-environment pathway into NeuroAxis at all.
Why the Protocol Matters as Much as the Capsules
The NeuropAWAY trial carries a lesson that has nothing to do with which bottle you buy. Everyone enrolled was B12-deficient and on metformin. Part of what the formula did, it did by fixing a deficiency that had a cause. That’s how nerve health usually works: the biggest gains come from addressing why the nerves are under stress, and a supplement works best on top of that, not instead of it.
The human evidence points the same way. The interventions that have actually increased nerve fiber density in people weren’t supplements. In a lifestyle intervention study in people with prediabetic neuropathy, a year of diet counseling and exercise increased the density of small nerve fibers in the skin. No capsule has matched that.
That’s why I treat any nerve support supplement, including my own, as the third and smallest of three pillars. And it’s why every NeuroAxis order includes the 160-page NeuroAxis Protocol at no extra cost:
Pillar 1, Nutrition: how to eat to stabilize blood sugar and reduce the metabolic stress that drives most neuropathy, including nutrients such as magnesium that are better covered by diet than by another capsule.
Pillar 2, Lifestyle: exercise, sleep and daily habits, the interventions with the strongest human evidence for nerve fiber regrowth.
Pillar 3, Targeted nutrients: where NeuroAxis fits, how to take it, and how to track whether it’s helping.
I found no comparable nutrition or lifestyle program offered with NeuropAWAY on the brand’s site. With NeuropAWAY, you get a bottle and a dosing chart. With NeuroAxis, you get the nutrients, the plan around them and a free 10-minute call with me if you have questions.
✦ KEY TAKEAWAY: The trial’s own B12 result shows that the cause of your symptoms matters as much as the capsule. The NeuroAxis Protocol is built around that: nutrition and lifestyle first, then targeted nutrients, with a way to track whether it’s working.
Where NeuroAxis Lands on the Same Yardstick
Since I’ve put NeuropAWAY’s trial and label under a microscope, here’s my own product held to the same standard, starting with where NeuropAWAY is ahead.
On clinical evidence, NeuropAWAY is ahead. NeuropAWAY has a randomized, double-blind, placebo-controlled trial of its finished formula. NeuroAxis doesn’t. I published two small studies of this same formula, then sold as NeuroGen, in patients recovering from endoscopic carpal tunnel release. NeuroAxis is the same formula as NeuroGen under a new name, so those studies tested the current formula, in carpal tunnel surgery patients rather than in neuropathy. Both were single-surgeon, non-randomized, with two-week follow-up, and neither studied neuropathy. I take them apart line by line in my NeuroAxis review.
On price, they’re even at the studied dose. NeuroAxis costs about $2.00 a day on subscription ($59.99 a month with free shipping, or $69.99 for a single bottle). NeuropAWAY costs $1.90 to $2.50 a day at the 6-capsule trial dose, the same six pills a day. At 2 capsules a day NeuropAWAY costs much less, but that isn’t the dose that was tested, and by the label order its R-ALA is no more than 240 mg.
On the label, NeuroAxis is ahead. Every dose is disclosed, so you can check each one against the research:
NeuroAxis daily dose (6 tablets): R-alpha-lipoic acid 600 mg, methylcobalamin 2,000 mcg, benfotiamine 300 mg, vitamin B6 10 mg (pyridoxine HCl), acetyl-L-carnitine 600 mg, N-acetyl cysteine 900 mg, CoQ10 150 mg, curcumin 500 mg with BioPerine 10 mg, vitamin D3 800 IU, bromelain 600 GDU and serrapeptase 40,000 SU.
• Alpha-lipoic acid at the studied dose, 600 mg of R-ALA, compared with no more than 240 mg per NeuropAWAY serving.
• Benfotiamine, the fat-soluble form of vitamin B1, at the lower of the two doses studied in BENDIP. NeuropAWAY has none.
• More B12, 2,000 mcg of methylcobalamin, above the roughly 1,500 mcg used in most neuropathy trials, compared with 720 mcg at NeuropAWAY’s trial dose.
• Four of the five pathways above, each at a stated dose.
Where NeuroAxis falls short. Acetyl-L-carnitine at 600 mg is below the 1,500 to 3,000 mg used by Sima. CoQ10 at 150 mg is below the 400 mg trial dose. Benfotiamine sits at the lower BENDIP arm. It doesn’t target circulation directly. And it’s six tablets a day.
What I can’t tell you is which works better. No study has compared them. What the difference buys is a label you can check, benfotiamine, more B12 and ALA at the studied dose, broader pathway coverage, and the Protocol. Not proven better results.
So the choice comes down to this. If a published trial of the finished product matters most to you, you fit the people it studied (type 2 diabetes, on metformin, not on insulin, age 40 to 65), and you’re willing to take 6 capsules a day, NeuropAWAY is the only product I’ve reviewed that offers one. If you’d rather know exactly what you’re taking, at doses you can check against the research, for about the same daily cost, with a step-by-step nutrition and lifestyle plan for the work that does the heaviest lifting, that’s what NeuroAxis and the NeuroAxis Protocol are built for.
✦ Which Path Fits You?
The right next step depends on where you are, not on which bottle wins a table.
|
You know what's driving your symptoms and want the full plan NeuroAxis with the 160-page NeuroAxis Protocol: the formula for the targeted-nutrient pillar, and the step-by-step nutrition and lifestyle plan for the two pillars that do the heaviest lifting. Most people start with the 3-Pack, because ingredient trials took roughly 4 to 12 weeks to show symptom change. It is also the lowest cost per bottle. Choose 1, 2 or 3 bottles, Protocol included → |
|
You want to start with nutrition and lifestyle before any supplement The NeuroAxis Protocol is also sold on its own. It is the same guide that comes free with every bottle, so if you add NeuroAxis later, you already have the plan. Get the Protocol ($14.99 ebook) → |
|
You don't know what's causing your symptoms yet Start with a free 10-minute phone call with me. I'll tell you honestly whether a supplement makes sense for your situation, or whether something needs to be checked first. Book a free 10-minute call → |
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. I formulated NeuroAxis and have a financial interest in it.
✦ KEY TAKEAWAY: NeuropAWAY has the stronger trial. At its studied dose, NeuroAxis costs about the same per day and gives you every dose on the label, ALA at the studied 600 mg, benfotiamine, more B12, broader pathway coverage and the 160-page Protocol.
En español: preguntas frecuentes sobre NeuropAWAY
¿Para qué sirve NeuropAWAY?
NeuropAWAY es una línea de suplementos de VasoCorp que, según la marca, apoya la función nerviosa saludable ante el ardor, el hormigueo y el entumecimiento ocasionales. Las cápsulas se estudiaron en un ensayo de seis semanas con 59 adultos con diabetes tipo 2. El gel se vende como cosmético para la piel seca y no se estudió en ese ensayo.
¿Cómo se toma NeuropAWAY?
La etiqueta de las cápsulas indica 2 cápsulas tres veces al día durante la primera semana y luego de 1 a 3 porciones (2 a 6 cápsulas) al día. El ensayo usó 6 cápsulas al día. NeuropAWAY PM se toma de 1 a 4 cápsulas antes de dormir. El gel se aplica en capa fina 3 o 4 veces al día.
¿Cuáles son los efectos secundarios de NeuropAWAY?
El ácido alfa lipoico puede causar náuseas o acidez y bajar el azúcar en la sangre. La beta-alanina puede causar un hormigueo pasajero en la piel. La L-citrulina puede bajar la presión arterial. NeuropAWAY PM contiene 15 mg de melatonina por cápsula y puede causar somnolencia al día siguiente. Consulte a su farmacéutico si toma medicamentos.
¿Cuánto cuesta NeuropAWAY y dónde se compra?
El 4 de noviembre de 2026, el frasco de 60 cápsulas costaba $18.97 en Amazon y Walmart y $19.99 en vasocorp.com. También se vende en CVS, H-E-B y tiendas Kroger. A 6 cápsulas al día, la dosis del ensayo, un frasco dura 10 días.
Estas declaraciones no han sido evaluadas por la Administración de Alimentos y Medicamentos (FDA). Este producto no está destinado a diagnosticar, tratar, curar ni prevenir ninguna enfermedad.
Frequently Asked Questions
Does NeuropAWAY really work?
In a 2023 randomized, double-blind trial of 59 adults with type 2 diabetes and painful neuropathy, 6 capsules a day for six weeks reduced pain scores far more than placebo. The trial was small, short, company-funded and not yet replicated, the placebo group barely changed, and nerve conduction didn’t improve. It didn’t test 2 capsules a day, PM or the gel.
Is NeuropAWAY clinically proven?
One published, placebo-controlled trial tested the capsule formula, at 6 capsules a day for 42 days, in B12-deficient adults with type 2 diabetes on metformin. That’s more evidence than most nerve supplements have. One small, company-funded trial isn’t proof, and no independent group has repeated it.
What are the ingredients in NeuropAWAY?
Per 2-capsule serving: 240 mcg of vitamin B12 as methylcobalamin, and a 1,200 mg proprietary blend of taurine, acetyl-L-carnitine, L-citrulline, beta-alanine and R-alpha-lipoic acid. The label doesn’t disclose individual amounts. Blend ingredients are listed by weight, and R-ALA is last, so it’s no more than 240 mg per serving.
Does NeuropAWAY gel work? What’s in it?
The brand labels the gel a cosmetic for burning and tingling of dry, flaky skin. It lists allantoin, vitamin E, CoQ10, vitamin D3 and acetyl-L-carnitine, with no drug ingredient. The published trial tested the capsules, not the gel, and I found no study showing these nutrients reach nerves through the skin.
NeuropAWAY gel vs pills: which is better?
They’re different kinds of products. The capsules are an oral supplement tested in one six-week trial at 6 capsules a day. The gel is a cosmetic skin product that hasn’t been tested for nerve symptoms. Some people use both. A pharmacist can suggest topical products with tested drug ingredients.
What are the side effects of NeuropAWAY?
Possible side effects include nausea or heartburn from alpha-lipoic acid, temporary skin tingling from beta-alanine, lower blood pressure from L-citrulline, and lower blood sugar. NeuropAWAY PM contains 15 mg of melatonin per capsule, which can cause next-day sleepiness. The trial reported no adverse events in 27 people over six weeks.
How much melatonin is in NeuropAWAY PM?
According to the Supplement Facts image on the brand’s PM product page, each capsule contains 15 mg of melatonin. The directions allow 1 to 4 capsules 30 minutes before bed, which is 15 to 60 mg. Start with one capsule and ask your pharmacist if you take other medications.
How many NeuropAWAY capsules should I take a day?
The label lists a 2-capsule serving, with 2 capsules three times a day for the first week and then 1 to 3 servings a day. The trial used 6 capsules a day throughout. At 2 capsules a day, you’re taking a third of the studied dose.
Who makes NeuropAWAY?
NeuropAWAY is made by VasoCorp, Inc., a family-owned company in Hiram, Georgia. Its founder and president, William Cross, is the named inventor on the capsule formula’s patent and was the first author of the published trial.
Where can I buy NeuropAWAY?
On November 4, 2026, NeuropAWAY was sold on vasocorp.com, Amazon and Walmart, in CVS, and in Kroger-family stores and H-E-B. The 60-capsule bottle was $18.97 on Amazon and Walmart and $19.99 on vasocorp.com.
How much does NeuropAWAY cost per day?
At 2 capsules a day, a 60-capsule bottle lasts 30 days, about $0.63 to $0.83 a day. At the 6-capsule trial dose, it lasts 10 days, about $1.90 to $2.50 a day, or roughly $57 to $75 a month.
Which is better, NeuropAWAY or Nervive?
They take different approaches, and neither has published a head-to-head study. Nervive Nerve Relief lists every dose, including 600 mg of alpha-lipoic acid, but has very little B12 and no benfotiamine. NeuropAWAY has a published trial of its capsules at 6 a day, but its main ingredients sit in an undisclosed blend. My Nervive review has the full label.
NeuropAWAY vs NeuroAxis: what’s the difference?
NeuropAWAY has a published placebo-controlled trial; NeuroAxis, which I formulated, doesn’t. At NeuropAWAY’s 6-capsule trial dose they cost about the same per day. NeuroAxis lists every dose, including 600 mg R-ALA, 2,000 mcg methylcobalamin and 300 mg benfotiamine, and includes the 160-page NeuroAxis Protocol. NeuropAWAY uses a proprietary blend.
Where to go from here
Explore NeuroAxis: the multi-pathway nerve support formula I developed, with the 160-page NeuroAxis Protocol included.*
Get the free Nerve Health Blueprint: my nutrition and lifestyle framework.
Talk with me directly: start with a free 10-minute call, or book a full consultation.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Label and Study Sources (Reviewed November 4, 2026)
NeuropAWAY: Supplement Facts and dosing images, product descriptions and prices from vasocorp.com/products/neuropaway-capsules, /neuropaway-pm and /maximum-strength-cooling-gel (neuropaway.com redirects to vasocorp.com). Refund policy from vasocorp.com/policies/refund-policy. Product list from vasocorp.com/collections/all. Prices and ratings from Amazon (ASINs B00VOLK8XI, B01MRTW45Y, B07G3J8XLD), Walmart (item 940046410), CVS (capsules and PM listings), and Mariano’s. H-E-B price from the H-E-B listing, November 4, 2026. US Patent 11,040,022, “Compositions and methods for pain relief,” inventor William H. Cross III, granted June 22, 2021. FDA Warning Letter CMS #732724 to VasoCorp, Inc., July 9, 2026.
Studies and references: Cross W, Srivastava S. J Pain Res 2023;16:1115–1126 (doi:10.2147/JPR.S397777; PMC10069439; NCT04504305). Frisaldi E, et al. Placebo and nocebo responses in painful diabetic neuropathy: systematic review and meta-analysis. Pain 2024;165:29–43 (doi:10.1097/j.pain.0000000000003000). Ziegler D, et al. SYDNEY 2. Diabetes Care 2006 (doi:10.2337/dc06-1216). Stracke H, et al. BENDIP. Exp Clin Endocrinol Diabetes 2008 (doi:10.1055/s-2008-1065351). Sawangjit R, et al. 2020 meta-analysis (PMID 32716261). Sima AAF, et al. Diabetes Care 2005 (doi:10.2337/diacare.28.1.89). Hershman DL, et al. SWOG S0715. J Clin Oncol 2013 (PMID 23733756). Smith AG, et al. Diabetes Care 2006 (doi:10.2337/dc05-2062). NCCIH, Melatonin: What You Need To Know. 21 CFR 101.36 (proprietary blend labeling).
About the Author
Dr. Michael Fitzmaurice, MD is a fellowship-trained peripheral nerve surgeon with a background in nerve physiology, metabolic health, and applied exercise physiology. Through years of surgical practice, during which he performed more than 3,000 peripheral nerve procedures, he observed the close relationship between metabolic health, cellular energy production, and nervous system function. His work focuses on how physical activity, recovery biology, and nutrition-informed strategies relate to long-term nerve and metabolic health.
He oversees Dr. Fitz Nutrition, an education-first initiative translating evidence-informed research into thoughtfully designed formulations for nerve and metabolic health, and believes that patients who understand the science make better decisions about their care.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Always consult a qualified healthcare provider regarding your individual medical situation. Product, price and label information reflects publicly available labels, brand pages and retailer listings as of November 4, 2026, and may change; check the current label before purchasing. NeuropAWAY is a trademark of VasoCorp. This article is independent and was not sponsored or approved by VasoCorp. Dr. Fitzmaurice formulated, and has a financial interest in, NeuroAxis, and is the author of both published studies on the same formula under its earlier name, NeuroGen.